Brief: Epigenomics To Increase Share Capital Through Rights Issue

Epigenomics AG

27/04/2021 16:32

April 27 (Reuters) - EPIGENOMICS AG  ECXn.DE :
    * DECIDES TO INCREASE SHARE CAPITAL THROUGH RIGHTS ISSUE
WITH
SUBSCRIPTION RIGHTS OF EXISTING SHAREHOLDERS
    * SHARE CAPITAL SHALL BE INCREASED FROM CURRENTLY EUR
9,852,690.00
BY UP TO EUR 1,970,538.00 TO UP TO EUR 11,823,228.00 BY ISSUING
UP TO 1,970,538 NEW REGISTERED NO PAR VALUE SHARES OF COMPANY
AGAINST CASH CONTRIBUTIONS
    * SUBSCRIPTION PRICE OF NEW SHARES WAS SET AT EUR 1.10
    * SUBSCRIPTION RATIO WILL BE 5:1
    * NEW SHARES WILL BE OFFERED TO COMPANY'S SHAREHOLDERS AS
PART OF
A PUBLIC OFFERING IN GERMANY BY WAY OF INDIRECT SUBSCRIPTION
RIGHTS DURING SUBSCRIPTION PERIOD, WHICH IS EXPECTED TO RUN FROM
3 MAY 2021 TO 17 MAY 2021

Source text for Eikon:  ID:nEQ9yHmHWa 
Further company coverage:  ECXn.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))